Gherardo Finocchiaro
Research Subjects
Gherardo Finocchiaro has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Gianfranco Sinagra
Cardiovascular Department, Azienda Sanitaria Universitaria Integrata, 34149 Trieste, Italy
13 shared publications Aleksandra Pavlovic
Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California
8 shared publications- Euan Angus Ashley
Stanford University School of Medicine
7 shared publications Francois Haddad
Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California
7 shared publicationsEmma Magavern
Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California
6 shared publicationsJonathan Myers
6 shared publications
Latest Publications
- 29 December 2017
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 20 (FI2) , f273
Unravelling the mystery behind sudden death in the young: a wake up call for nationwide autopsy-based approach
We read with great interest the article by Wisten et al.1 regarding the epidemiology and the causes of sudden cardiac death (SCD) in young individuals in Sweden.
- 29 December 2017
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 20 (FI2) , f273
Unravelling the mystery behind sudden death in the young: a wake up call for nationwide autopsy-based approach
We read with great interest the article by Wisten et al.1 regarding the epidemiology and the causes of sudden cardiac death (SCD) in young individuals in Sweden.
- 1 March 2016
- Published by Wiley in Echocardiography
- Vol. 33 (5) , 686-694
Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy
Background and aims: Both myectomy and alcohol septal ablation (ASA) can substantially reduce left ventricular (LV) outflow obstruction, relieve symptoms, and improve outcomes in hypertrophic cardiomyopathy (HCM). It is unclear whether septal reduction decreases left atrial (LA) size and improves diastolic function. The aim of this study was to analyze the consequences of septal reduction on LA size and diastolic function in a cohort of patients with HCM.Methods: Forty patients (mean age: 50 ± 14, male sex 64%) with HCM who underwent septal reduction (myectomy or alcohol septal ablation) were studied. Retrospective analyses of echocardiograms preprocedure, postprocedure, and at 1 year of follow‐up were performed.Results: Thirty‐one patients had septal myectomy and 9 ASA. The degree of reduction in rest peak LV outflow tract gradient was significant (57 ± 32 vs. 23 ± 20 mmHg at 1 year, P < 0.001). Maximal interventricular septal thickness decreased from 22 ± 6 mm preprocedure to 19 ± 4 mm postprocedure (P < 0.001); moderate‐to‐severe mitral regurgitation (MR) was initially present in 34% of the sample and only 2% after the procedure. Average LA volume index (LAVI) decreased from 63 ± 20 to 55 ± 20 mL/m2 at the 1‐year follow‐up (P < 0.001). We did not observe a significant improvement in diastolic function at Doppler (E/A 1.2 ± 0.4 vs. 1.1 ± 0.5, P = 0.07; E’ 7.6 ± 3.6 vs. 6.9 ± 3.0, P = 0.4) pre‐ and postprocedure, respectively). At 1 year, only 5% of the patients were severely symptomatic (NYHA III). On multivariate analysis, a significant change in the LVOT gradient during stress (Δ gradient ≥30 mmHg) was the only variable independently associated with LAVI reverse remodeling >10 mL/m2 [OR = 6.4 (CI 95% 1.12–36.44), P = 0.04].Conclusions: Septal reduction is effective in the relief of LV obstruction and symptoms in patients with HCM. The hemodynamic changes result in a significant LA reverse remodeling, but not in an improvement of diastolic function in these patients.
- 1 March 2016
- Published by Wiley in Echocardiography
- Vol. 33 (5) , 686-694
Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy
Background and aims: Both myectomy and alcohol septal ablation (ASA) can substantially reduce left ventricular (LV) outflow obstruction, relieve symptoms, and improve outcomes in hypertrophic cardiomyopathy (HCM). It is unclear whether septal reduction decreases left atrial (LA) size and improves diastolic function. The aim of this study was to analyze the consequences of septal reduction on LA size and diastolic function in a cohort of patients with HCM.Methods: Forty patients (mean age: 50 ± 14, male sex 64%) with HCM who underwent septal reduction (myectomy or alcohol septal ablation) were studied. Retrospective analyses of echocardiograms preprocedure, postprocedure, and at 1 year of follow‐up were performed.Results: Thirty‐one patients had septal myectomy and 9 ASA. The degree of reduction in rest peak LV outflow tract gradient was significant (57 ± 32 vs. 23 ± 20 mmHg at 1 year, P < 0.001). Maximal interventricular septal thickness decreased from 22 ± 6 mm preprocedure to 19 ± 4 mm postprocedure (P < 0.001); moderate‐to‐severe mitral regurgitation (MR) was initially present in 34% of the sample and only 2% after the procedure. Average LA volume index (LAVI) decreased from 63 ± 20 to 55 ± 20 mL/m2 at the 1‐year follow‐up (P < 0.001). We did not observe a significant improvement in diastolic function at Doppler (E/A 1.2 ± 0.4 vs. 1.1 ± 0.5, P = 0.07; E’ 7.6 ± 3.6 vs. 6.9 ± 3.0, P = 0.4) pre‐ and postprocedure, respectively). At 1 year, only 5% of the patients were severely symptomatic (NYHA III). On multivariate analysis, a significant change in the LVOT gradient during stress (Δ gradient ≥30 mmHg) was the only variable independently associated with LAVI reverse remodeling >10 mL/m2 [OR = 6.4 (CI 95% 1.12–36.44), P = 0.04].Conclusions: Septal reduction is effective in the relief of LV obstruction and symptoms in patients with HCM. The hemodynamic changes result in a significant LA reverse remodeling, but not in an improvement of diastolic function in these patients.
- 1 July 2015
- Published by Elsevier in Journal of Cardiology
- Vol. 66 (1) , 57-62
Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
- 1 July 2015
- Published by Elsevier in Journal of Cardiology
- Vol. 66 (1) , 57-62
Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
- 1 May 2015
- Published by Elsevier in JACC: Heart Failure
- Vol. 3 (5) , 408-418
Cardiopulmonary Responses and Prognosis in Hypertrophic Cardiomyopathy
- 1 May 2015
- Published by Elsevier in JACC: Heart Failure
- Vol. 3 (5) , 408-418
Cardiopulmonary Responses and Prognosis in Hypertrophic Cardiomyopathy
- 1 May 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (5) , 419-425
Prevalence and Prognostic Role of Right Ventricular Involvement in Stress-Induced Cardiomyopathy
- 1 May 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (5) , 419-425
Prevalence and Prognostic Role of Right Ventricular Involvement in Stress-Induced Cardiomyopathy
- 30 June 2014
- Published by Springer Nature
- p. 207-247
Infiltrative/Storage Cardiomyopathies: Clinical Assessment and Imaging in Diagnosis and Patient Management
- 30 June 2014
- Published by Springer Nature
- p. 207-247
Infiltrative/Storage Cardiomyopathies: Clinical Assessment and Imaging in Diagnosis and Patient Management
- 30 June 2014
- Published by Springer Nature
- p. 109-116
Advanced Echocardiographic Technologies in Hypertrophic Cardiomyopathy
- 30 June 2014
- Published by Springer Nature
- p. 109-116
Advanced Echocardiographic Technologies in Hypertrophic Cardiomyopathy